Trade VSTM anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Verastem, Inc. (VSTM) is trading at US$8.29, up 1.04% today as of Sep 8, 13:58 EDT. The company has a market capitalisation of US$623.98M. Over the past 52 weeks, VSTM has traded between US$3.43 and US$10.82. On Syfe you can trade VSTM with $0 commission and add it to your watchlist.
| Previous close | US$8.20 |
|---|---|
| Market cap | US$623.98M |
| 52-week range | US$3.43 – US$10.82 |
| Volume | 2.3M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Verastem, Inc.
Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.
Year: 2012
RBC Capital Adjusts Verastem Price Target to $14 From $15, Maintains Outperform Rating
Jul 7, 12:11 PM · MT Newswires
Verastem's VS-7375 Update Reiterates Potential in US Patients, RBC Says
Jun 24, 3:13 PM · MT Newswires
Verastem Says VS-7375 Trial Data Shows Anti-Tumor Activity in Advanced Solid Tumors
Jun 23, 8:44 PM · MT Newswires
Verastem Doses First Patient in Phase 2 Trial of VS-7375 for Pancreatic Cancer
Jun 16, 8:25 PM · MT Newswires
Verastem, Inc. (VSTM) stock is trading at US$8.29, +1.04% from the previous close of US$8.20.
The market cap for Verastem, Inc. (VSTM) stock is approximately US$623.98M.
The 52-week high for Verastem, Inc. (VSTM) stock is US$10.82.
The 52-week low for Verastem, Inc. (VSTM) stock is US$3.43.
Verastem, Inc. (VSTM) does not currently pay a dividend.
Stay on top of VSTM
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
